MOL THER 润色咨询

MOLECULAR THERAPY

出版年份:2000 年文章数:2211 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2022-06-06 ms3000000242801209

    molecular therapy在肿瘤口碑怎么样?难度如何

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    文章类型和选刊有关系吗?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2021-08-18 二手科学家

    这个杂志最近貌似快成lncRNA专刊了

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2019-03-19 princesun083

    审稿速度:24.0 | 投稿命中率:25.0
    经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2020-01-19 145fac5am20暂无昵称

    需要188****6831暂无昵称 2020-01-05 发表::
    请问需要原始数据吗?
    188****6831暂无昵称 2020-01-05 00:00:00 发表:
    请问需要原始数据吗?

    188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2020-06-17 哈哈这就是学术圈

    好杂志

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2023-01-31 陈爸爸吧 来自广东省

    投稿的时候无法填基金怎么办

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2019-02-06 拼搏必成

    年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表::
    完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。
    Dr H 2019-02-06 00:00:00 发表:
    完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。

    Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2019-03-28 fame198288

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样?难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0<br>经验分享:历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要<span class="quote">188****6831暂无昵称 2020-01-05 发表::<br>请问需要原始数据吗?</span><span class="quote">188****6831暂无昵称 2020-01-05 00:00:00 发表:<br>请问需要原始数据吗?</span>, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112427, encodeId=653d211242e69, content=投稿的时候无法填基金怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmFzSicR3biaesfR4JYnNA6yvkEEDt0HZUfNfMYfmzEHl2Yp6icQhkEg0nHJSFnjvOBQyRWAS4Ar5DQ/132, createdBy=59bf2570128, createdName=陈爸爸吧, createdTime=Tue Jan 31 19:31:24 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇,接收率应该是《10%的。我8月初投稿稿件号已经2880了。<span class="quote">Dr H 2019-02-06 发表::<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span><span class="quote">Dr H 2019-02-06 00:00:00 发表:<br>完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。</span>, beContent=Dr H 2019-02-06 发表:: 完全同意,虽然这个软件很不错,但是这个软件错误信息太多了,官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:非常好的杂志,之前为nature出版社,现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志,势头强进。审稿较快,一般一个月以内,快的2周,审稿人都是本领域大牛,问题一针见血,修稿时间有时不给期限限制,有的多达10个月反复修改。收取版面费,超过8页加钱,彩图收费,且投稿时要明确说明哪些是彩图。课题创新性要强,实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展?一审时间多久啊?<span class="quote">princesun083 2019-03-19 00:00:00 发表:<br>历经审稿一年多,终于收了,这个杂志不要审稿太仔细!</span>, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2019-03-20 nanana

    能否分享一下整个过程进展?一审时间多久啊?princesun083 2019-03-19 00:00:00 发表:
    历经审稿一年多,终于收了,这个杂志不要审稿太仔细!

    princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多,终于收了,这个杂志不要审稿太仔细!

    0

共206条页码: 3/21页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分